Skip to main content
Signal8

ProMIS Neurosciences to Participate in Upcoming Conferences in June

$PMNPress releaseMay 28, 2026, 10:13 AM ET

ProMIS Neurosciences will participate in several major healthcare conferences in June 2026, including presentations at the Jefferies Global Healthcare Conference and Wolfe Research’s Virtual Alzheimer’s R&D Day. CEO Neil Warma will discuss the company’s EpiSelect platform and lead Alzheimer’s candidate PMN310, which targets toxic amyloid-beta oligomers.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.